NAD


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
23 08 2019
Historique:
received: 28 02 2019
accepted: 23 07 2019
entrez: 24 8 2019
pubmed: 24 8 2019
medline: 15 2 2020
Statut: ppublish

Résumé

SARM1 (sterile alpha and TIR motif containing 1) is responsible for depletion of nicotinamide adenine dinucleotide in its oxidized form (NAD

Identifiants

pubmed: 31439792
pii: 365/6455/793
doi: 10.1126/science.aax1911
doi:

Substances chimiques

Armadillo Domain Proteins 0
Cytoskeletal Proteins 0
L6 protein, Linum usitatissimum 0
Plant Proteins 0
Receptors, Immunologic 0
SARM1 protein, human 0
NAD 0U46U6E8UK
NADP 53-59-8
NAD+ Nucleosidase EC 3.2.2.5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

793-799

Subventions

Organisme : Medical Research Council
ID : MR/N004582/1
Pays : United Kingdom
Organisme : Australian Research Council
Pays : International

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Shane Horsefield (S)

School of Chemistry and Molecular Biosciences, Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, QLD 4072, Australia.

Hayden Burdett (H)

School of Chemistry and Molecular Biosciences, Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, QLD 4072, Australia.

Xiaoxiao Zhang (X)

Agriculture and Food, Commonwealth Scientific and Industrial Research Organisation, Canberra, ACT 2601, Australia.
Plant Sciences Division, Research School of Biology, The Australian National University, Canberra ACT 2601, Australia.

Mohammad K Manik (MK)

School of Chemistry and Molecular Biosciences, Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, QLD 4072, Australia.

Yun Shi (Y)

Institute for Glycomics, Griffith University, Southport, QLD 4222, Australia.

Jian Chen (J)

Agriculture and Food, Commonwealth Scientific and Industrial Research Organisation, Canberra, ACT 2601, Australia.
Plant Sciences Division, Research School of Biology, The Australian National University, Canberra ACT 2601, Australia.

Tiancong Qi (T)

Department of Plant and Microbial Biology, University of California Berkeley, Berkeley, CA 94720, USA.

Jonathan Gilley (J)

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, ED Adrian Building, Forvie Site, Robinson Way, Cambridge CB2 0PY, UK.
Babraham Institute, Babraham, Cambridge CB22 3AT, UK.

Jhih-Siang Lai (JS)

School of Chemistry and Molecular Biosciences, Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, QLD 4072, Australia.

Maxwell X Rank (MX)

School of Chemistry and Molecular Biosciences, Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, QLD 4072, Australia.

Lachlan W Casey (LW)

School of Chemistry and Molecular Biosciences, Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, QLD 4072, Australia.
Centre for Microscopy and Microanalysis, University of Queensland, Brisbane, QLD 4072, Australia.

Weixi Gu (W)

School of Chemistry and Molecular Biosciences, Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, QLD 4072, Australia.

Daniel J Ericsson (DJ)

Macromolecular Crystallography (MX) Beamlines, Australian Synchrotron, Melbourne, VIC 3168, Australia.

Gabriel Foley (G)

School of Chemistry and Molecular Biosciences, Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, QLD 4072, Australia.

Robert O Hughes (RO)

Disarm Therapeutics, 400 Technology Square, Cambridge, MA 02139, USA.

Todd Bosanac (T)

Disarm Therapeutics, 400 Technology Square, Cambridge, MA 02139, USA.

Mark von Itzstein (M)

Institute for Glycomics, Griffith University, Southport, QLD 4222, Australia.

John P Rathjen (JP)

Plant Sciences Division, Research School of Biology, The Australian National University, Canberra ACT 2601, Australia.

Jeffrey D Nanson (JD)

School of Chemistry and Molecular Biosciences, Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, QLD 4072, Australia.

Mikael Boden (M)

School of Chemistry and Molecular Biosciences, Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, QLD 4072, Australia.

Ian B Dry (IB)

Agriculture and Food, Commonwealth Scientific and Industrial Research Organisation, Urrbrae, SA 5064, Australia.

Simon J Williams (SJ)

Plant Sciences Division, Research School of Biology, The Australian National University, Canberra ACT 2601, Australia.

Brian J Staskawicz (BJ)

Department of Plant and Microbial Biology, University of California Berkeley, Berkeley, CA 94720, USA.

Michael P Coleman (MP)

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, ED Adrian Building, Forvie Site, Robinson Way, Cambridge CB2 0PY, UK.
Babraham Institute, Babraham, Cambridge CB22 3AT, UK.

Thomas Ve (T)

School of Chemistry and Molecular Biosciences, Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, QLD 4072, Australia. b.kobe@uq.edu.au t.ve@griffith.edu.au peter.dodds@csiro.au.
Institute for Glycomics, Griffith University, Southport, QLD 4222, Australia.

Peter N Dodds (PN)

Agriculture and Food, Commonwealth Scientific and Industrial Research Organisation, Canberra, ACT 2601, Australia. b.kobe@uq.edu.au t.ve@griffith.edu.au peter.dodds@csiro.au.

Bostjan Kobe (B)

School of Chemistry and Molecular Biosciences, Institute for Molecular Bioscience and Australian Infectious Diseases Research Centre, University of Queensland, Brisbane, QLD 4072, Australia. b.kobe@uq.edu.au t.ve@griffith.edu.au peter.dodds@csiro.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH